Steve Morgan
GET UPDATES FROM Steve Morgan
 
Steve Morgan is an expert advisor with EvidenceNetwork.ca and Associate Professor and Associate Director of the Centre for Health Services and Policy Research at the University of British Columbia.

Entries by Steve Morgan

The New Brunswick Drug Plan With Great Potential

(1) Comments | Posted January 7, 2014 | 3:56 PM

The Alward government has just adopted pharmacare reforms that have great potential to do good -- and great potential to cost New Brunswickers far more than it should.

The New Brunswick Drug Plan bears little resemblance to catastrophic drug plans in other provinces. That is a good thing.

All models...

Read Post

The Incoming Rise of Prescription Drug Spending

(0) Comments | Posted December 18, 2013 | 11:27 AM

Canadians spent almost $23-billion on prescription drugs at retail pharmacies in 2012/13 -- or over $650 per capita, according to the findings from the Canadian Rx Atlas published this week by the UBC Centre for Health Services and Policy Research. That is a lot of money. However, after adjusting for...

Read Post

How Canada's Pharmacare System Is Costing Us Billions

(2) Comments | Posted April 2, 2013 | 5:45 PM

Another budget cycle has passed without remedy for the biggest unresolved problem in our health care system. From 1980 to 2010, spending on pharmaceuticals used outside of hospitals in Canada grew more than 15-fold, from just under $2-billion to just over $30-billion. Yes, billion.

In contrast, spending on...

Read Post

Moving to Income-Based Drug Coverage is the Wrong Prescription for Alberta

(1) Comments | Posted March 27, 2013 | 3:38 PM

The Alberta government has announced major pharmacare reforms: the province is planning
to move from a system where public drug coverage is available mainly for seniors to a system
where coverage will be restricted based upon income. Experience from other provinces suggests
that income-based pharmacare will not...

Read Post

Canadians Are Over-Paying for Pharmaceuticals Year After Year

(4) Comments | Posted February 27, 2013 | 11:20 PM

When the topic of universal drug coverage comes up in this country, the debate often runs aground on the question of cost. In an environment of government austerity, few seem willing to embrace the idea of a new, national government program.

But a single-payer, universal system would not bankrupt the...

Read Post

Canada's Drug Patent Process Needs Rx

(0) Comments | Posted November 20, 2012 | 1:51 PM

Last week the federal government signalled that, to reach a new trade agreement with Europe, it might extend pharmaceutical patents. The move could cost Canadians up to $2 billion per year. Supporters argue that it will attract research investment and generate jobs.

But longer drug patents will...

Read Post